Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD
Open Access
- 23 June 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-30
Abstract
Generally, inflammatory bowel disease (IBD) can be caused by psychology, genes, environment, and gut microbiota. Therefore, IBD therapy should be improved to utilize multiple strategies. Shen Ling Bai Zhu San (SLBZS) adheres to the aim of combating complex diseases from an integrative and holistic perspective, which is effective for IBD therapy. Herein, a systems pharmacology and microbiota approach was developed for these molecular mechanisms exemplified by SLBZS. First, by systematic absorption-distribution-metabolism-excretion (ADME) analysis, potential active compounds and their corresponding direct targets were retrieved. Then, the network relationships among the active compounds, targets, and disease were built to deduce the pharmacological actions of the drug. Finally, an “IBD pathway” consisting of several regulatory modules was proposed to dissect the therapeutic effects of SLBZS. In addition, the effects of SLBZS on gut microbiota were evaluated through analysis of the V3-V4 region and multivariate statistical methods. SLBZS significantly shifted the gut microbiota structure in a rat model. Taken together, we found that SLBZS has multidimensionality in the regulation of IBD-related physiological processes, which provides new sights into herbal medicine for the treatment of IBD.Keywords
Funding Information
- National Natural Science Foundation of China (31472232)
This publication has 87 references indexed in Scilit:
- Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune SystemJournal of Ginseng Research, 2012
- The Chemokine Superfamily RevisitedImmunity, 2012
- NF-κB, the first quarter-century: remarkable progress and outstanding questionsGenes & Development, 2012
- Calcium signals and calpain-dependent necrosis are essential for release of coxsackievirus B from polarized intestinal epithelial cellsMolecular Biology of the Cell, 2011
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Cytoscape 2.8: new features for data integration and network visualizationBioinformatics, 2010
- Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectivesMicrobiology, 2010
- Gut Microbiota in Health and DiseasePhysiological Reviews, 2010
- Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic SamplesPLOS Computational Biology, 2009
- PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomasJournal of Cancer Research and Clinical Oncology, 2005